These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 20701978)
1. Efficacy and safety of nonbenzodiazepine hypnotics for chronic insomnia in patients with bipolar disorder. Schaffer CB; Schaffer LC; Miller AR; Hang E; Nordahl TE J Affect Disord; 2011 Feb; 128(3):305-8. PubMed ID: 20701978 [TBL] [Abstract][Full Text] [Related]
2. Greater incidence of depression with hypnotic use than with placebo. Kripke DF BMC Psychiatry; 2007 Aug; 7():42. PubMed ID: 17711589 [TBL] [Abstract][Full Text] [Related]
3. Possibility that certain hypnotics might cause cancer in skin. Kripke DF J Sleep Res; 2008 Sep; 17(3):245-50. PubMed ID: 18844818 [TBL] [Abstract][Full Text] [Related]
4. Hypnotics and skin cancer: hint at drug carcinogenesis, coincidence, or benefit of more sleep? Friedman GD J Sleep Res; 2008 Sep; 17(3):243-4. PubMed ID: 18844817 [No Abstract] [Full Text] [Related]
5. [How well do Z-substances help in insomnia?]. Baier PC MMW Fortschr Med; 2013 Jun; 155(12):30. PubMed ID: 23923306 [No Abstract] [Full Text] [Related]
6. Sleeping pills: are they worth the risk? Consum Rep; 2006 Sep; 71(9):48-9. PubMed ID: 16929577 [No Abstract] [Full Text] [Related]
7. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia. Najib J Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462 [TBL] [Abstract][Full Text] [Related]
9. Correlates of dependence and beliefs about the use of hypnotics among zolpidem and zopiclone users. Yen CF; Yen CN; Ko CH; Hwang TJ; Chen CS; Chen TT; Su PW; Chen ST; Lin JJ Subst Use Misuse; 2015 Feb; 50(3):350-7. PubMed ID: 25458710 [TBL] [Abstract][Full Text] [Related]
10. NICE: The National Institute of Clinical Excellence -- or Eccentricity? Reflections on the Z-drugs as hypnotics. Nutt DJ J Psychopharmacol; 2005 Mar; 19(2):125-7. PubMed ID: 15728430 [No Abstract] [Full Text] [Related]
11. A NICE missed opportunity? Lader M J Psychopharmacol; 2005 Mar; 19(2):136-8. PubMed ID: 15728434 [No Abstract] [Full Text] [Related]
12. Drugs for Insomnia. Med Lett Drugs Ther; 2015 Jul; 57(1472):95-8. PubMed ID: 26147892 [No Abstract] [Full Text] [Related]
13. Hypnotic discontinuation in chronic insomnia: impact of psychological distress, readiness to change, and self-efficacy. Belleville G; Morin CM Health Psychol; 2008 Mar; 27(2):239-48. PubMed ID: 18377143 [TBL] [Abstract][Full Text] [Related]
14. Meds and the restless search for sleep. Health News; 2006 Apr; 12(4):7. PubMed ID: 16575946 [No Abstract] [Full Text] [Related]
15. Comparative tolerability of newer agents for insomnia. Zammit G Drug Saf; 2009; 32(9):735-48. PubMed ID: 19670914 [TBL] [Abstract][Full Text] [Related]
17. Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies. Rosenberg RP Ann Clin Psychiatry; 2006; 18(1):49-56. PubMed ID: 16517453 [TBL] [Abstract][Full Text] [Related]
18. A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia. Erman MK; Zammit G; Rubens R; Schaefer K; Wessel T; Amato D; Caron J; Walsh JK J Clin Sleep Med; 2008 Jun; 4(3):229-34. PubMed ID: 18595435 [TBL] [Abstract][Full Text] [Related]
19. Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement. Montplaisir J; Hawa R; Moller H; Morin C; Fortin M; Matte J; Reinish L; Shapiro CM Hum Psychopharmacol; 2003 Jan; 18(1):29-38. PubMed ID: 12532313 [No Abstract] [Full Text] [Related]
20. The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial. Tek C; Palmese LB; Krystal AD; Srihari VH; DeGeorge PC; Reutenauer EL; Guloksuz S Schizophr Res; 2014 Dec; 160(1-3):180-5. PubMed ID: 25454802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]